State Street Corp raised its holdings in shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) by 2.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 157,495 shares ...
Acquisition builds on the company’s revenue recovery portfolio with increased support for Amazon sellersCompany to host conference call today at ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate of 52,188 shares of common stock, 33,885 restricted stock units ...
It is anticipated that upon completion of the Consolidation, the post-Consolidation Common Shares will continue to trade on the TSX under the symbol “ BCT ” and on the Nasdaq under the symbol “ BCTX ” ...
Lazar is purchasing 1,000,000 shares of C Preferred Stock for $1,000,000 at an initial closing to occur on or about January 3, 2025. Each share of C Preferred Stock is convertible into 2.65 shares of ...
The inducement grants were approved by ORIC’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635 (c) (4), and were granted as a material inducement to employment in ...
Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, ...
EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market 03.01.2025 / 22:15 CET/CEST The issuer is solely ...
Aegis Capital Corp. acted as exclusive placement agent for the offerings. Stradling Yocca Carlson & Rauth LLP acted as counsel to the Company. Kaufman & Canoles, P.C. acted as counsel to Aegis Capital ...
Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The ...
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its fourth quarter and full year 2024 financial results announcement. Senior management will be available for questions ...
Ascentage Pharma Group International (HK:6855) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended ...